Notes:
* Strong up trend
* Not the best earnings
* Tested historical resistance of $6.17 around mid June
* Broke and retested historical resistance of $7.43 just recently
* Printed a pocket pivot and is still relatively close to its 50 day line
* The Healthcare sector is doing relatively well compared to others
Technicals:
Sector: Healthcare - Biotechnology
Relative Strength vs. Sector: 1.77
Relative Strength vs. SP500: 1.41
U/D Ratio: 1.59
Base Depth: 38.68%
Distance from breakout buy point: -10.42%
Volume 62.59% above its 15 day avg.
Trade Idea:
* You can enter now as the price is still close to its 50 day line and the price is just bouncing off of historical resistance with higher than average volume.
* If you're looking for a better entry you can look for one around the $7.62 area
* This stock usually has local tops when the price closes around 21.31% above its 50 EMA
* Consider selling into strength if the price closes 21.11% to 21.51% (or higher) above its 50 EMA
* The last closing price is 8.25% away from its 50 EMA
* Strong up trend
* Not the best earnings
* Tested historical resistance of $6.17 around mid June
* Broke and retested historical resistance of $7.43 just recently
* Printed a pocket pivot and is still relatively close to its 50 day line
* The Healthcare sector is doing relatively well compared to others
Technicals:
Sector: Healthcare - Biotechnology
Relative Strength vs. Sector: 1.77
Relative Strength vs. SP500: 1.41
U/D Ratio: 1.59
Base Depth: 38.68%
Distance from breakout buy point: -10.42%
Volume 62.59% above its 15 day avg.
Trade Idea:
* You can enter now as the price is still close to its 50 day line and the price is just bouncing off of historical resistance with higher than average volume.
* If you're looking for a better entry you can look for one around the $7.62 area
* This stock usually has local tops when the price closes around 21.31% above its 50 EMA
* Consider selling into strength if the price closes 21.11% to 21.51% (or higher) above its 50 EMA
* The last closing price is 8.25% away from its 50 EMA
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.
Penafian
Maklumat dan penerbitan adalah tidak dimaksudkan untuk menjadi, dan tidak membentuk, nasihat untuk kewangan, pelaburan, perdagangan dan jenis-jenis lain atau cadangan yang dibekalkan atau disahkan oleh TradingView. Baca dengan lebih lanjut di Terma Penggunaan.